← All trials
NCT06457958
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2024
- Primary completion
- Dec 1, 2024
- Completion date
- Jan 31, 2025
- First posted
- Jun 13, 2024
- Last posted
- Aug 27, 2024
- Enrollment
- 48
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Kocaeli City HospitalLead sponsor
- Kocaeli City HospitalOfficial
- The Scientific and Technological Research Council of TurkeyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.